Back to search
PolG, Primary Mitochondrial Myopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which PolG, Primary Mitochondrial Myopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which PolG, Primary Mitochondrial Myopathy trials you may qualify forSPIMD-301 is a 48-week, randomized, double-blind, parallel-group, placebo-controlled trial to assess efficacy and safety of single daily subcutaneous (SC) admin…
Source material collection of videos to develop the Mitochondrial Video Assessment (MVA) for patients with mitochondrial myopathies.